BioCryst Pharmaceuticals, Inc. (BCRX) was a big mover last session, as its shares rose almost 11% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This continues the trend for the healthcare company since Feb 6, as it is now up nearly 42%.
In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
BioCryst currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Other well-performing stocks in the medical sector include WuXi PharmaTech (Cayman) Inc. (WX), Karyopharm Therapeutics, Inc. (KPTI) and Aratana Therapeutics, Inc. (PETX). All three carry the same Zacks Rank as BioCryst.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
KARYOPHARM THERAPEUTICS INC (KPTI): Free Stock Analysis Report
BIOCRYST PHARMACEUTICALS INC (BCRX): Free Stock Analysis Report
WUXI PHARMATECH CAYMAN INC (WX): Free Stock Analysis Report
ARATANA THERAPEUTICS INC (PETX): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Personal Investing Ideas & Strategies